[
  {
    "title": "AAV as a gene therapy vector",
    "summary": "How adeno-associated virus acts as a delivery vehicle for therapeutic payloads.",
    "icon": "/icons/aav-vector.svg",
    "points": [
      "AAV is a small virus engineered to carry a custom DNA cassette into target cells without causing disease.",
      "Capsid \"shells\" are selected to match tissues—liver, muscle, CNS—based on known biodistribution maps.",
      "Once inside the cell, the cassette remains mostly episomal, producing the intended protein without integrating into the genome."
    ]
  },
  {
    "title": "Principles of gene therapy",
    "summary": "The scaffold Axnmihn uses to decide when a gene therapy program is safe, precise, and accountable.",
    "icon": "/icons/gene-therapy.svg",
    "points": [
      "Start with measurable disease markers, then design payloads that sense and respond to those signals.",
      "Layer logic gates—AND, OR, NOT—to control when expression happens, adding safety in complex tissues.",
      "Monitor with paired analytics so every dose feeds back into the decision support system for future iterations."
    ]
  }
]
